Chargement en cours...
Five years of local control of subscapularis aggressive fibromatosis managed by surgery and imatinib: a case report
INTRODUCTION: Imatinib, a tyrosine kinase inhibitor, is a major therapeutic option for the management of unresectable aggressive fibromatosis. Unfortunately, for most patients of low or very low average income countries, surgery often is the first treatment option. This is related to unavailability...
Enregistré dans:
| Publié dans: | J Med Case Rep |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4307220/ https://ncbi.nlm.nih.gov/pubmed/25488584 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1752-1947-8-416 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|